Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 239 institutions that hold shares in the stock, with a total of 73.9 Million shares, which have been reported (via 13F filing form) to have a value of $3.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
835,100
shares
|
$34 Million
0.06% of portfolio
|
Q3 2025
Reduced 35.27%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
812,761
shares
|
$33.1 Million
1.28% of portfolio
|
Q2 2025
Added 10.92%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 14, 2025 Q3 2025 |
799,743
shares
|
$32.6 Million
4.82% of portfolio
|
Q3 2025
Added 21.06%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
720,659
shares
|
$29.4 Million
0.0% of portfolio
|
Q3 2025
Added 28.28%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
695,900
shares
|
$28.4 Million
0.01% of portfolio
|
Q3 2025
Added 4.42%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 07, 2025 Q3 2025 |
670,257
shares
|
$27.3 Million
0.07% of portfolio
|
Q3 2025
Added 1.39%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
659,257
shares
|
$26.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 3.03%
|
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
655,737
shares
|
$26.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 70.52%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2025 Q3 2025 |
640,626
shares
|
$26.1 Million
0.03% of portfolio
|
Q3 2025
Reduced 2.52%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
611,982
shares
|
$24.9 Million
0.03% of portfolio
|
Q3 2025
Reduced 40.02%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
599,113
shares
|
$24.4 Million
0.01% of portfolio
|
Q3 2025
Added 678.65%
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
579,145
shares
|
$23.6 Million
0.04% of portfolio
|
Q3 2025
Added 11.06%
|
|
|
Times Square Capital Management, LLC
|
Nov 07, 2025 Q3 2025 |
556,800
shares
|
$22.7 Million
0.36% of portfolio
|
Q3 2025
Reduced 2.53%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
542,020
shares
|
$22.1 Million
0.41% of portfolio
|
Q2 2025
New holding
|
|
|
Fiera Capital Corp
Montreal, A8 |
Nov 07, 2025 Q3 2025 |
519,999
shares
|
$21.2 Million
0.07% of portfolio
|
Q3 2025
Reduced 2.01%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
503,701
shares
|
$20.5 Million
4.44% of portfolio
|
Q3 2025
Added 7.54%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
503,398
shares
|
$20.5 Million
3.66% of portfolio
|
Q3 2025
Added 55.66%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
498,147
shares
|
$20.3 Million
0.0% of portfolio
|
Q3 2025
Added 1.68%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
454,023
shares
|
$18.5 Million
0.0% of portfolio
|
Q3 2025
Added 19.48%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
419,600
shares
|
$17.1 Million
0.57% of portfolio
|
Q3 2025
Reduced 55.73%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
396,636
shares
|
$16.2 Million
0.09% of portfolio
|
Q2 2025
Reduced 12.76%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
370,208
shares
|
$15.1 Million
0.12% of portfolio
|
Q2 2025
Added 6.56%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
366,572
shares
|
$14.9 Million
0.0% of portfolio
|
Q3 2025
Reduced 5.42%
|
|
|
Tri Locum Partners LP
New York, NY |
Nov 14, 2025 Q3 2025 |
366,102
shares
|
$14.9 Million
4.04% of portfolio
|
Q3 2025
New holding
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
322,456
shares
|
$13.1 Million
0.02% of portfolio
|
Q3 2025
Added 368.22%
|
|